Amphastar Pharmaceuticals, Inc.
6 active drug shortages reported by Amphastar Pharmaceuticals, Inc..
Morphine Sulfate Injection
- Category
- Analgesia/Addiction
- Reason
- Not specified
- Updated
- 04/02/2026
Sodium Bicarbonate Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/02/2026
Lorazepam Injection
- Category
- Neurology
- Reason
- Demand increase for the drug
- Updated
- 04/02/2026
Atropine Sulfate Injection
- Category
- Anesthesia
- Reason
- Not specified
- Updated
- 04/02/2026
Dextrose Monohydrate 50% Injection
- Category
- Endocrinology/Metabolism
- Reason
- Demand increase for the drug
- Updated
- 04/02/2026
Lidocaine Hydrochloride Injection
- Category
- Anesthesia
- Reason
- Not specified
- Updated
- 03/23/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.